Neurodegenerative Diseases Treatment in Cancun, Mexico

After you’ve been selected a candidate for a neurodegenerative disease therapy, you will meet with our highly-trained team of medical professionals to devise a treatment plan tailored specifically to have the best results possible given your current condition. Below we will outline the different methods of administering cellular therapies that we use in our medical facilities:

intrathecal-intraarterial
This form of implantation is ideal for neurological conditions because the stem cells are injected past the blood-brain barrier and directly into the spinal fluid, which enables them to reach the spinal cord and brain.

During the procedure, an experienced anesthesiologist inject stem cells into the spinal canal through the lower vertebrae under local anesthesia. They are all performed in a positive airflow room under sterile conditions, and the procedure usually takes about thirty minutes.

Intravenous IV
The safest and simplest method for delivering the neurodegenerative stem cells throughout the body. Anesthesia is not required. We may use Lidocaine topical spray to needle prick area beforehand. IV administration usually takes about 20 – 30 minutes.

Intramuscular IM
The stem cells are injected directly into the muscle. Intramuscular implantation is very safe and does not require anesthesia.

The Cellular Hope Institute’s offices are located in the Amerimed Hospital in Cancun, which is accredited both by the Mexican General Health Council and the Canadian Accreditation Council. There, we have a highly-qualified team in many specialties, including pediatricians, radiologists, neurologists, anesthesiologists and regenerative medicine specialists, who convene with each other to produce the most reliable, efficable patient experience available.

Aside from it’s proximity to the United States and pleasant climate and sights, Our facilities in Cancun are top-notch, and include a laboratory to culture-expand cells, a process that yields better patient results, and a cryopreservation unit to keep these extracted samples stored safely until they are needed.  At our clinic, you will find the best neurodegenerative disease treatment outside of the US.

Your journey will begin as you depart from your hometown for beautiful Cancún, México. In Cancún they will be greeted at the International Airport by our patient coordinator, then transferred to your accommodations. Once settled in, the patient coordinator will provide them a welcome package that will contain:

• • • • • City vouchers.
        •  A list of frequently asked questions. 
        • Contact info during your stay.

First Consultation
The day before your procedure takes place, you will have a one-on-one with your specialized team, at which point your attending physician will go over your procedure and expectations. At this time, you may ask your doctor any additional questions you may have. This day will include:

• • • • • Analysis of current condition of the patient.
        • New lab tests run.
        •  Specialist doctor evaluation according to the medical condition to be treated.
        • Anesthesia evaluation.
        • Establishment of final protocols to follow according to previous indicators.

Treatment Day
You will be picked up two hours before the procedure is scheduled to begin, please ensure that you do not eat eight hours before the procedure.  

Once you arrive at the hospital you will be asked to sign all the necessary patient consent forms and you will be prepped for your procedure.

The procedure will take 3-4 hours, once the cells are harvested and prepared they will be administered to the patient in accordance with their . After the procedure is complete you will either be returned to your hotel or, depending on the procedure, your hospital suite for overnight observation.

A standard procedure for highly manipulated stem cells cell would be the following:

 Extraction of bone marrow or fat sample. In the case of young children, who do not have very much adipose tissue, a bone marrow extraction through the iliac crest (hip bone) is usually performed. 

Procedure is performed with local anesthesia and sedation, meaning there is little pain.After the sample is extracted, it is processed and isolated to obtain fresh mesenchymal cells. Approximately 80% of the mesenchymal cells obtained go directly to the patient, either through arterial catheterization in the case of neurological illness, or intrathecally to other damaged organs. The other 20% are sent to the lab to be expanded, a process which is known as the high manipulation of stem cells. The patient stays overnight for close clinical motoring.

Post-Operative Care
The day after the patient’s procedure, you will go to your follow up appointment, where your garment and bandages will be removed, your incisions will be cleaned and inspected, and you will get your first ultrasound scan. 

Booster with highly manipulated stem cells:
(Sixth day stay). The physician or patient coordinator will notify you for the procedure with the stem cells that have been expanded in the laboratory. The patient receives a final booster through systematic approach via an intravenous line with the cultured cells. 

After this, the physician team will make a final evaluation and, most likely, discharge the patient. 

Departure day
A driver will pick you and the patient up at your accommodation, and you will be dropped off at the airport at least two hours prior to your flight’s departure. Your patient coordinator will let you know when the next virtual consultation will take place.

There is a virtual Assessment for Follow-Up treatment that serves as monitoring for the patient’s condition, and will be requested both before and after the treatment. In addition, there will continue to be post-treatment assessments required.

Parkinson’s disease
In Parkinson’s disease, certain nerve cells (neurons) in the brain gradually break down or die. Many of the symptoms are due to a loss of neurons that produce a chemical messenger in your brain called dopamine. When dopamine levels decrease, it causes abnormal brain activity, leading to symptoms of Parkinson’s disease.

The cause of Parkinson’s disease is unknown, but several factors appear to play a role, including:

Your genes. Researchers have identified specific genetic mutations that can cause Parkinson’s disease. But these are uncommon except in rare cases with many family members affected by Parkinson’s disease.

However, certain gene variations appear to increase the risk of Parkinson’s disease but with a relatively small risk of Parkinson’s disease for each of these genetic markers.

Environmental triggers. Exposure to certain toxins or environmental factors may increase the risk of later Parkinson’s disease, but the risk is relatively small.

Researchers have also noted that many changes occur in the brains of people with Parkinson’s disease, although it’s not clear why these changes occur. These changes include:

The presence of Lewy bodies. Clumps of specific substances within brain cells are microscopic markers of Parkinson’s disease. These are called Lewy bodies, and researchers believe these Lewy bodies hold an important clue to the cause of Parkinson’s disease.

Alpha-synuclein is found within Lewy bodies. Although many substances are found within Lewy bodies, scientists believe an important one is the natural and widespread protein called alpha-synuclein (a-synuclein). It’s found in all Lewy bodies in a clumped form that cells can’t break down. This is currently an important focus among Parkinson’s disease researchers, and especially when it comes to effective neurodegenerative disease treatments.

Alzheimer’s disease
Scientists believe that for most people, Alzheimer’s disease is caused by a combination of genetic, lifestyle and environmental factors that affect the brain over time.

Less than 1 percent of the time, Alzheimer’s is caused by specific genetic changes that virtually guarantee a person will develop the disease. These rare occurrences usually result in disease onset in middle age.

The exact causes of Alzheimer’s disease aren’t fully understood, but at its core are problems with brain proteins that fail to function normally, disrupt the work of brain cells (neurons) and unleash a series of toxic events. Neurons are damaged, lose connections to each other and eventually die.

The damage most often starts in the region of the brain that controls memory, but the process begins years before the first symptoms. The loss of neurons spreads in a somewhat predictable pattern to other regions of the brain. By the late stage of the disease, the brain has shrunk significantly.

When seeking effective neurodegenerative disease treatments, researchers are focused on the role of two proteins:
Plaques. Beta-amyloid is a leftover fragment of a larger protein. When these fragments cluster together, they appear to have a toxic effect on neurons and to disrupt cell-to-cell communication. These clusters form larger deposits called amyloid plaques, which also include other cellular debris.

Tangles. Tau proteins play a part in a neuron’s internal support and transport system to carry nutrients and other essential materials. In Alzheimer’s disease, tau proteins change shape and organize themselves into structures called neurofibrillary tangles. The tangles disrupt the transport system and are toxic to cells.

Huntington’s disease
Huntington’s disease is caused by an inherited defect in a single gene. Huntington’s disease is an autosomal dominant disorder, which means that a person needs only one copy of the defective gene to develop the disorder.

With the exception of genes on the sex chromosomes, a person inherits two copies of every gene — one copy from each parent. A parent with a defective gene could pass along the defective copy of the gene or the healthy copy. Each child in the family, therefore, has a 50 percent chance of inheriting the gene that causes the genetic disorder.